JSAM
TXG icon

J. Safra Asset Management’s 10x Genomics TXG Stock Holding History

J. Safra Asset Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.3K Sell
504
-111
-18% -$2.91K ﹤0.01% 330
2026
Q1 		$13.1K Buy
615
+411
+201% +$8.22K ﹤0.01% 351
2025
Q4 		$3.33K Buy
+204
New +$3.08K ﹤0.01% 488
2025
Q2 		– Sell
-257
Closed -$2.24K – 399
2025
Q1 		$2.24K Buy
257
+218
+559% +$2.75K ﹤0.01% 325
2024
Q4 		$560 Hold
39
– – ﹤0.01% 322
2024
Q3 		$884 Buy
+39
New +$806 ﹤0.01% 276
2023
Q1 		– Sell
-50
Closed -$1K – 129
2022
Q4 		$1K Buy
+50
New +$1.64K ﹤0.01% 69

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

J. Safra Asset Management's TXG Position: Q2 2026 in Review

J. Safra Asset Management reduced its 10x Genomics (TXG) stake by 18% in Q2 2026, selling an estimated $2.91K and leaving 504 shares worth $19.3K. The position accounts for ﹤0.01% of the portfolio, ranked #330.

J. Safra Asset Management first reported a position in TXG in Q4 2022 and has held it in 7 quarters since. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • J. Safra Asset Management held 504 shares of 10x Genomics worth $19.3K as of Q2 2026.
  • J. Safra Asset Management sold 111 10x Genomics shares in Q2 2026, an estimated $2.91K.
  • 10x Genomics made up ﹤0.01% of J. Safra Asset Management's portfolio in Q2 2026, its #330 holding.
  • J. Safra Asset Management first reported a position in 10x Genomics in Q4 2022 and has held it in 7 quarters since.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on J. Safra Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.